JP2017513962A - 生体高分子誘導体の合成方法、生体高分子誘導体およびその使用 - Google Patents

生体高分子誘導体の合成方法、生体高分子誘導体およびその使用 Download PDF

Info

Publication number
JP2017513962A
JP2017513962A JP2016553492A JP2016553492A JP2017513962A JP 2017513962 A JP2017513962 A JP 2017513962A JP 2016553492 A JP2016553492 A JP 2016553492A JP 2016553492 A JP2016553492 A JP 2016553492A JP 2017513962 A JP2017513962 A JP 2017513962A
Authority
JP
Japan
Prior art keywords
biopolymer
chitosan
derivative
molecule
glutathione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016553492A
Other languages
English (en)
Japanese (ja)
Inventor
バル，ヴォイチェフ
ザヴィシャ，イザベラ
フロンチク，トマシュ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instytut Biochemii I Biofizyki of PAN
Original Assignee
Instytut Biochemii I Biofizyki of PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL407257A external-priority patent/PL234156B1/pl
Priority claimed from PL407258A external-priority patent/PL235482B1/pl
Application filed by Instytut Biochemii I Biofizyki of PAN filed Critical Instytut Biochemii I Biofizyki of PAN
Publication of JP2017513962A publication Critical patent/JP2017513962A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D105/00—Coating compositions based on polysaccharides or on their derivatives, not provided for in groups C09D101/00 or C09D103/00
    • C09D105/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B23/00—Obtaining nickel or cobalt
    • C22B23/04—Obtaining nickel or cobalt by wet processes
    • C22B23/0453—Treatment or purification of solutions, e.g. obtained by leaching
    • C22B23/0461—Treatment or purification of solutions, e.g. obtained by leaching by chemical methods
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B3/00—Extraction of metal compounds from ores or concentrates by wet processes
    • C22B3/20—Treatment or purification of solutions, e.g. obtained by leaching
    • C22B3/44—Treatment or purification of solutions, e.g. obtained by leaching by chemical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Dermatology (AREA)
  • Manufacturing & Machinery (AREA)
  • Wood Science & Technology (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Geology (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Environmental & Geological Engineering (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
JP2016553492A 2014-02-19 2015-02-19 生体高分子誘導体の合成方法、生体高分子誘導体およびその使用 Pending JP2017513962A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PL407257A PL234156B1 (pl) 2014-02-19 2014-02-19 Pochodna polioligosacharydu, chitation i kompozycja farmaceutyczna zawierająca chitation do zastosowania do zapobiegania alergii wywołanej metalami ciężkimi
PLP.407258 2014-02-19
PLP.407257 2014-02-19
PL407258A PL235482B1 (pl) 2014-02-19 2014-02-19 Sposób syntezy pochodnej chitozanu, pochodna chitozanu otrzymana tym sposobem, kompozycja kosmetyczna zawierająca pochodną chitozanu i zastosowanie pochodnej chitozanu
PCT/PL2015/000023 WO2015126269A1 (en) 2014-02-19 2015-02-19 Method for synthesis of a biopolymer derivative, a biopolymer derivative and its use

Publications (1)

Publication Number Publication Date
JP2017513962A true JP2017513962A (ja) 2017-06-01

Family

ID=52823760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016553492A Pending JP2017513962A (ja) 2014-02-19 2015-02-19 生体高分子誘導体の合成方法、生体高分子誘導体およびその使用

Country Status (15)

Country Link
US (1) US20170056508A1 (enExample)
EP (1) EP3107941B1 (enExample)
JP (1) JP2017513962A (enExample)
KR (1) KR20160122828A (enExample)
CN (1) CN106132978A (enExample)
AU (1) AU2015219586A1 (enExample)
BR (1) BR112016018758B1 (enExample)
CA (1) CA2938964A1 (enExample)
CL (1) CL2016002063A1 (enExample)
DK (1) DK3107941T3 (enExample)
EA (1) EA201691655A1 (enExample)
IL (1) IL247393A0 (enExample)
MX (1) MX2016010696A (enExample)
SG (2) SG11201606662QA (enExample)
WO (1) WO2015126269A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021178805A (ja) * 2020-05-15 2021-11-18 株式会社 資生堂 金属アレルギー原因物質ブロック剤

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109569240B (zh) * 2018-12-14 2021-08-13 山东汇之蓝环保科技有限公司 高效脱硝离子液及其使用方法
CN109847572A (zh) * 2018-12-24 2019-06-07 深圳市寰保化工科技有限公司 一种微生物气泡液及其制备方法和应用
CN113521110B (zh) * 2021-07-12 2023-04-07 深圳零一生命科技有限责任公司 一种缓释抗逆性益生菌晶球及其制备方法
CN113842464B (zh) * 2021-09-24 2023-07-04 江苏贝美医疗科技有限公司 一种类风湿因子吸附材料及其制备方法与应用
AR130056A1 (es) * 2022-08-02 2024-10-30 Kannar Earth Science Ltd Composiciones y métodos para controlar patógenos de plantas que incluyen nematodos
CN116036358A (zh) * 2022-12-29 2023-05-02 南京大学 一种三维打印抗菌水凝胶材料及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10204104A (ja) * 1997-01-27 1998-08-04 Kiresuto Giken:Kk キトサン誘導体及びその製法並びに金属イオン吸着剤
JP2014518289A (ja) * 2011-06-13 2014-07-28 ライバル，ソシエテ エン コマンダイト Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009636A1 (en) 1990-11-30 1992-06-11 Baker Cummins Dermatologicals, Inc. Skin protective compositions and method of inhibiting skin irritation
CA2126132A1 (en) 1994-06-17 1995-12-18 Witold Neugebauer Peptide synthesis on chitosan
US20070299034A1 (en) * 2002-02-12 2007-12-27 Marie-France Versali Cell wall derivatives, their preparation process, and use thereof
DE10338110A1 (de) 2003-08-15 2005-03-10 Biomet Deutschland Gmbh Mit Chitosan beschichteter metallischer Gegenstand sowie Verfahren zu dessen Herstellung
RU2357738C2 (ru) 2007-07-09 2009-06-10 Государственное образовательное учреждение высшего профессионального образования "КРАСНОЯРСКАЯ ГОСУДАРСТВЕННАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" Способ профилактики платиноза кожи
CN101759812A (zh) * 2009-12-28 2010-06-30 中国药科大学 一种新型仿穿膜肽结构的壳聚糖衍生物
CN102133433B (zh) * 2011-03-09 2013-12-18 中国人民解放军军事医学科学院基础医学研究所 一种可注射性心肌组织工程产品及其制备方法
PL233402B1 (pl) * 2012-08-03 2019-10-31 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Sposób oczyszczania ścieków o wysokiej zawartości metali, zwłaszcza srebra i miedzi
CN103266153B (zh) * 2013-06-17 2014-12-31 江西科技师范大学 一种改性壳聚糖的生产方法
CN104012839B (zh) * 2014-05-19 2016-04-06 中国人民解放军军事医学科学院基础医学研究所 保健品制备用壳聚糖-多肽复合物及其制备方法
CN104387503A (zh) * 2014-12-11 2015-03-04 湖南科技大学 壳聚糖-还原型谷胱甘肽聚合物的制备方法及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10204104A (ja) * 1997-01-27 1998-08-04 Kiresuto Giken:Kk キトサン誘導体及びその製法並びに金属イオン吸着剤
JP2014518289A (ja) * 2011-06-13 2014-07-28 ライバル，ソシエテ エン コマンダイト Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BIOMATERIALS, vol. 34, JPN6019000325, 2013, pages 9071 - 9081, ISSN: 0004170365 *
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. Vol.59(20), JPN6019000326, 2011, pages 11264 - 11269, ISSN: 0004170367 *
JOURNAL OF APPLIED POLYMER SCIENCE, vol. Vol.124(6), JPN6019000327, 2012, pages 5046 - 5055, ISSN: 0004170368 *
PHARMACEUTICAL RESEARCH, vol. Vol.22(9), JPN6019000329, 2005, pages 1480 - 1488, ISSN: 0004170366 *
VESTNIK MOSKOVSKOGO UNIVERSITETA, SERIYA 2: KHIMIYA, vol. Vol.41(6), JPN6019000330, 2000, pages 398 - 401, ISSN: 0004170369 *
糖化学の基礎, JPN6019000328, 10 August 1995 (1995-08-10), pages 139 - 141, ISSN: 0004170370 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021178805A (ja) * 2020-05-15 2021-11-18 株式会社 資生堂 金属アレルギー原因物質ブロック剤
JP7587928B2 (ja) 2020-05-15 2024-11-21 株式会社 資生堂 金属アレルギー原因物質ブロック剤

Also Published As

Publication number Publication date
CA2938964A1 (en) 2015-08-27
AU2015219586A1 (en) 2016-08-18
BR112016018758A2 (enExample) 2017-08-08
SG11201606662QA (en) 2016-09-29
CL2016002063A1 (es) 2017-05-26
WO2015126269A4 (en) 2015-10-01
MX2016010696A (es) 2017-04-27
EA201691655A1 (ru) 2017-01-30
KR20160122828A (ko) 2016-10-24
EP3107941B1 (en) 2025-07-16
EP3107941A1 (en) 2016-12-28
WO2015126269A1 (en) 2015-08-27
BR112016018758B1 (pt) 2022-04-12
IL247393A0 (en) 2016-11-30
DK3107941T3 (da) 2025-10-20
US20170056508A1 (en) 2017-03-02
CN106132978A (zh) 2016-11-16
SG10201806997QA (en) 2018-09-27

Similar Documents

Publication Publication Date Title
JP2017513962A (ja) 生体高分子誘導体の合成方法、生体高分子誘導体およびその使用
Yadav et al. Short to ultrashort peptide-based hydrogels as a platform for biomedical applications
Zhou et al. Stimuli-responsive peptide hydrogels for biomedical applications
Fu et al. Protein-based bioactive coatings: from nanoarchitectonics to applications
US10117946B2 (en) Self-assembling ultrashort peptides modified with bioactive agents by click chemistry
Balasco et al. Amyloid-like aggregation in diseases and biomaterials: osmosis of structural information
DK2895198T3 (en) NON-COVALENT SELF-ORGANIZING HYDROGEL MATRIX FOR BIOTECHNOLOGICAL APPLICATIONS
Khoo et al. Staphylococcus aureus resistance on titanium coated with multivalent PEGylated-peptides
JP2010535225A (ja) コラーゲン関連ペプチド及びその使用
TW201533061A (zh) 糖鏈-多肽複合物
Cheng et al. New synthesis route of hydrogel through a bioinspired supramolecular approach: gelation, binding interaction, and in vitro dressing
Cherkupally et al. Solid-phase peptide synthesis (SPPS), C-terminal vs. side-chain anchoring: a reality or a myth
Kim et al. Thickness-tunable eggshell membrane hydrolysate nanocoating with enhanced cytocompatibility and neurite outgrowth
Seghir et al. Preparation methods keratin and nanoparticles keratin from wool: a review
JP2007191643A (ja) 生体への定着性が付与されたポリアミノ酸誘導体
Xu et al. Injectable and Biocompatible Mussel‐Inspired Adhesive for Enhanced Reendothelialization of Injured Artery
CN114618024A (zh) 一种内皮功能仿生材料、其制备方法及应用
JPH07509704A (ja) グリシルーヒスチジルーリシン（ｇｈｌ）誘導体
US20230000904A1 (en) Anti-hemorrhaging compositions
CN109734900A (zh) 一种可酶降解型多肽基聚酯氨及其制备方法和应用
CN110028557B (zh) 一种Ce6标记的双链抗菌肽及其合成方法和应用
JPH04327600A (ja) ペプチド複合体およびそれを有効成分とする医薬
Zúñiga-Bustos et al. Unveiling the potential of RADA16-I peptide-coated silver nanoparticles for biomedical uses: a computational study
PL235482B1 (pl) Sposób syntezy pochodnej chitozanu, pochodna chitozanu otrzymana tym sposobem, kompozycja kosmetyczna zawierająca pochodną chitozanu i zastosowanie pochodnej chitozanu
Ding et al. The Sources, Synthesis, and Applications of Cyclopeptides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161118

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190412

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190617

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190716

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20191210